110 related articles for article (PubMed ID: 15483480)
1. Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant: nephrogenic fibrosing dermopathy and graft vs host disease.
Gremmels JM; Kirk GA
Clin Nucl Med; 2004 Nov; 29(11):694-7. PubMed ID: 15483480
[TBL] [Abstract][Full Text] [Related]
2. Absent skeletal uptake of (99m)Tc-hydroxymethylene diphosphonate in the presence of AL-type amyloidosis associated with multiple myeloma.
Sasaki T; Okizaki A; Takahashi K; Mineta M; Nagasawa K; Fujimoto Y; Kohda K; Aburano T
Jpn J Radiol; 2011 Oct; 29(8):595-7. PubMed ID: 21928004
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous graft-versus-host disease on Tc-99m leukocyte scintigraphy.
Mittra E; McDougall IR
Clin Nucl Med; 2009 Dec; 34(12):894-5. PubMed ID: 20139825
[No Abstract] [Full Text] [Related]
4. Abnormal uptake of Technetium-99 m hydroxymethylene diphosphonate in the liver.
Roman MR; Larcos G; Angelides S; Devadas M
Australas Radiol; 2003 Mar; 47(1):73-4. PubMed ID: 12581061
[TBL] [Abstract][Full Text] [Related]
5. What is the value of Tc-99m hydroxymethylene diphosphonate scintigraphy for the etiological diagnosis of mild rhabdomyolysis?
Esnault VL; Nakhla M; Delcroix C; Moutel MG; Couturier O
Clin Nucl Med; 2007 Jul; 32(7):519-23. PubMed ID: 17581334
[TBL] [Abstract][Full Text] [Related]
6. Extraosseous uptake of Tc-99m HDP in muscular dystrophy.
Nye PJ; Aelion JA; Odhav SK; Bain S
Clin Nucl Med; 2000 Feb; 25(2):135-6. PubMed ID: 10656652
[No Abstract] [Full Text] [Related]
7. Extraosseous uptake of metastatic lymph nodes of ureteral cancer on 99Tcm hydroxymethylene diphosphonate bone scintigraphy.
Kaida H; Ishibashi M; Baba K; Nishida H; Matsuoka K; Hayabuchi N
Br J Radiol; 2004 Oct; 77(922):869-70. PubMed ID: 15483000
[No Abstract] [Full Text] [Related]
8. Extraosseous uptake of Tc-99m methylene diphosphonate in the pectoralis muscles 8 days after exercise.
Groell R; Aigner R
Clin Nucl Med; 2000 Jan; 25(1):65-6. PubMed ID: 10634541
[No Abstract] [Full Text] [Related]
9. Focal skeletal muscle uptake of 99mTechnetium-hydroxymethylene diphosphonate following peroneal nerve blocks in horses.
Griffin JF; Young BD; Fosgate GT; Walker MA; Watkins JP
Vet Radiol Ultrasound; 2010; 51(3):338-43. PubMed ID: 20469559
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m MDP bone scintigraphy of myositis as a manifestation of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation.
Mitomo M; Miyazaki C; Mukai M; Usami Y; Nagano S; Nakamura N; Kubo K
Ann Nucl Med; 2005 Feb; 19(1):41-5. PubMed ID: 15770972
[TBL] [Abstract][Full Text] [Related]
11. Splenic accumulation of Tc-99m HMDP in a patient with severe alcoholic cirrhosis of the liver.
Kawamura E; Kawabe J; Hayashi T; Oe A; Kotani J; Torii K; Habu D; Shiomi S
Clin Nucl Med; 2005 May; 30(5):351-2. PubMed ID: 15827413
[TBL] [Abstract][Full Text] [Related]
12. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
13. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of Tc-99m HDP in adductor magnus caused by squatting exercises.
Graves NK; Mitchell J; Harris J; Tsikouris J; Meyerrose GE
Clin Nucl Med; 2005 Mar; 30(3):189-90. PubMed ID: 15722826
[No Abstract] [Full Text] [Related]
15. Ga-67 uptake in cutaneous lesions of graft-versus-host disease.
Nuñez RF; Yeung HW; Macapinlac HA; Castro-Malaspina H; Larson SM
Clin Nucl Med; 2000 Sep; 25(9):676-8. PubMed ID: 10983752
[TBL] [Abstract][Full Text] [Related]
16. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of bone scintigraphy of the spinous processes of the equine thoracic spine at different times after administering ⁹⁹mTc-hydroxymethylene-diphosphonate.
Sporn A; Berner D; Winter K; Mageed M; Brehm W; Gerlach K
Vet Rec; 2014 May; 174(20):505. PubMed ID: 24578315
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
19. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
20. Hepatoma accumulation of Tc-99m hydroxymethylene diphosphonate.
Burke T; Fukumoto D; Cohen A; Johnson AC
Clin Nucl Med; 1983 Jun; 8(6):275. PubMed ID: 6307579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
